Hypoxia and Medicine

Insomnia Medical Condition News

Press ReleaseTuesday, July 19, 2011 @ 8:01AMMillennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited (TSE:4502) today announced the submission of a supplemental New Drug Application (sNDA) with the U.S. Food and Drug Administration (FDA) for VELCADE® (bortezomib) for injection to add overall survival (OS) data after a five-year follow up to the product label.

Unique Health and Beauty Clinic Opens on French RivieraTuesday, July 19, 2011 @ 7:08AMCAP D'ANTIBES, France, July 19, 2011 /PRNewswire/ -- Since opening its doors last month, Le Clinique Science & Beaute has received glowing reviews from its clients, ranging from celebrities and VIPs to stressed out executives, athletes and jet-setters, making it a resounding success for a venue to go and rejuvenate, in just a matter of weeks. Based on the glamorous Cap d'Antibes and founded by ...

Millennium Submits Supplemental New Drug Application with FDA for Long-Term Overall Survival Results of VELCADE in ...Tuesday, July 19, 2011 @ 6:11AMMillennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company ...

Insight into global incidence and prevalence of mild cognitive impairmentTuesday, July 19, 2011 @ 4:54AMNew research reported today in Paris at the Alzheimer's Association International Conference 2011 (AAIC 2011) offers insight on the global incidence and prevalence of mild cognitive impairment (MCI) – a condition involving problems with memory or another mental function severe enough to be noticeable to the affected person or to others but not serious enough to interfere with daily life.

The Placebo Effect, This Time in AsthmaThursday, July 14, 2011 @ 2:27PMResearchers found stark differences in the objective measure of lung function and how patients actually felt.